Literature DB >> 10602560

Current Approach to Antithrombotic Therapy: An Abbreviated Reference for Practicing Clinicians.

.   

Abstract

Year:  1996        PMID： 10602560     DOI： 10.1007/BF00133074

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN： 0929-5305            Impact factor:   2.300


× No keyword cloud information.
  9 in total

1.  A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group.

Authors:  S Schulman; A S Rhedin; P Lindmarker; A Carlsson; G Lärfars; P Nicol; E Loogna; E Svensson; B Ljungberg; H Walter
Journal:  N Engl J Med       Date:  1995-06-22       Impact factor: 91.245

2.  Tissue plasminogen activator for acute ischemic stroke.

Authors: 
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

3.  Low-molecular-weight heparin for the treatment of acute ischemic stroke.

Authors:  R Kay; K S Wong; Y L Yu; Y W Chan; T H Tsoi; A T Ahuja; F L Chan; K Y Fong; C B Law; A Wong
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

4.  Efficacy of long-term anticoagulant treatment in subgroups of patients after myocardial infarction.

Authors:  P F van Bergen; J W Deckers; J J Jonker; R T van Domburg; A J Azar; A Hofman
Journal:  Br Heart J       Date:  1995-08

5.  Effects of low dose aspirin (50 mg/day), low dose aspirin plus dipyridamole, and oral anticoagulant agents after internal mammary artery bypass grafting: patency and clinical outcome at 1 year. CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands. Prevention of Coronary Artery Bypass Graft Occlusion by Aspirin, Dipyridamole and Acenocoumarol/Phenprocoumon Study.

Authors:  J van der Meer; A Brutel de la Rivière; W H van Gilst; H L Hillege; M Pfisterer; G J Kootstra; P H Dunselman; B J Mulder; K I Lie
Journal:  J Am Coll Cardiol       Date:  1994-11-01       Impact factor: 24.094

6.  Effect of dietary supplementation with n-3 fatty acids on coronary artery bypass graft patency.

Authors:  J Eritsland; H Arnesen; K Grønseth; N B Fjeld; M Abdelnoor
Journal:  Am J Cardiol       Date:  1996-01-01       Impact factor: 2.778

7.  Efficacy and safety of combined anticoagulant and antiplatelet therapy versus anticoagulant monotherapy after mechanical heart-valve replacement: a metaanalysis.

Authors:  J C Cappelleri; L D Fiore; M T Brophy; D Deykin; J Lau
Journal:  Am Heart J       Date:  1995-09       Impact factor: 4.749

8.  Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia.

Authors: 
Journal:  N Engl J Med       Date:  1995-07-06       Impact factor: 91.245

9.  The Subcutaneous Heparin and Angioplasty Restenosis Prevention (SHARP) trial. Results of a multicenter randomized trial investigating the effects of high dose unfractionated heparin on angiographic restenosis and clinical outcome.

Authors:  M J Brack; S Ray; A Chauhan; J Fox; P J Hubner; P Schofield; A Harley; A H Gershlick
Journal:  J Am Coll Cardiol       Date:  1995-10       Impact factor: 24.094
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.